|
1
|
Howlader N, Forjaz G, Mooradian MJ, Meza
R, Kong CY, Cronin KA, Mariotto AB, Lowy DR and Feuer EJ: The
effect of advances in lung-cancer treatment on population
mortality. N Engl J Med. 383:640–649. 2020. View Article : Google Scholar
|
|
2
|
de Groot PM, Wu CC, Carter BW and Munden
RF: The epidemiology of lung cancer. Transl Lung Cancer Res.
7:220–233. 2018. View Article : Google Scholar
|
|
3
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar
|
|
4
|
Oudkerk M, Devaraj A, Vliegenthart R,
Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N,
Mascalchi M, Delorme S, et al: European position statement on lung
cancer screening. Lancet Oncol. 18:e754–e766. 2017. View Article : Google Scholar
|
|
5
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar
|
|
6
|
Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y
and Lu Y: ACT001, a novel PAI-1 inhibitor, exerts synergistic
effects in combination with cisplatin by inhibiting PI3K/AKT
pathway in glioma. Cell Death Dis. 10:7572019. View Article : Google Scholar
|
|
7
|
Zhong W, Hou H, Liu T, Su S, Xi X, Liao Y,
Xie R, Jin G, Liu X, Zhu L, et al: Cartilage oligomeric matrix
protein promotes epithelial-mesenchymal transition by interacting
with transgelin in colorectal cancer. Theranostics. 10:8790–8806.
2020. View Article : Google Scholar
|
|
8
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3:170222017. View Article : Google Scholar
|
|
9
|
Li K, Sun D, Gou Q, Ke X, Gong Y, Zuo Y,
Zhou JK, Guo C, Xia Z, Liu L, et al: Long non-coding RNA linc00460
promotes epithelial-mesenchymal transition and cell migration in
lung cancer cells. Cancer Lett. 420:80–90. 2018. View Article : Google Scholar
|
|
10
|
Liao J, Wang J, Liu Y, Li J and Duan L:
Transcriptome sequencing of lncRNA, miRNA, mRNA and interaction
network constructing in coronary heart disease. BMC Med Genomics.
12:1242019. View Article : Google Scholar
|
|
11
|
Li Y, Zhu G, Ma Y and Qu H: LncRNA CCAT1
contributes to the growth and invasion of gastric cancer via
targeting miR-219-1. J Cell Biochem. 120:19457–19468. 2019.
View Article : Google Scholar
|
|
12
|
Li P, Zhang N, Ping F, Gao Y and Cao L:
lncRNA SCAL1 inhibits inducible nitric oxide synthase in lung cells
under high-glucose conditions. Exp Ther Med. 18:1831–1836.
2019.
|
|
13
|
Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L,
Yang Q, Zhu H, Nie J, Wu C, et al: LncRNA MIR100HG promotes cell
proliferation in triple-negative breast cancer through triplex
formation with p27 loci. Cell Death Dis. 9:8052018. View Article : Google Scholar
|
|
14
|
Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu
K, Yang P, Dai C, Zhu Y, Zheng Y, et al: The impact of lncRNA
dysregulation on clinicopathology and survival of breast cancer: A
systematic review and meta-analysis. Mol Ther Nucleic Acids.
12:359–369. 2018. View Article : Google Scholar
|
|
15
|
Bo C, Li X, He L, Zhang S, Li N and An Y:
A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular
carcinoma progression through stabilizing HHIP mRNA. Biochem
Biophys Res Commun. 520:333–340. 2019. View Article : Google Scholar
|
|
16
|
Xi X, Chu Y, Liu N, Wang Q, Yin Z, Lu Y
and Chen Y: Joint bioinformatics analysis of underlying potential
functions of hsa-let-7b-5p and core genes in human glioma. J Transl
Med. 17:1292019. View Article : Google Scholar
|
|
17
|
Pipan V, Zorc M and Kunej T: MicroRNA
polymorphisms in cancer: A literature analysis. Cancers (Basel).
7:1806–1814. 2015. View Article : Google Scholar
|
|
18
|
Wong HA, Fatimy RE, Onodera C, Wei Z, Yi
M, Mohan A, Gowrisankaran S, Karmali P, Marcusson E, Wakimoto H, et
al: The Cancer Genome Atlas analysis predicts microRNA for
targeting cancer growth and vascularization in glioblastoma. Mol
Ther. 23:1234–1247. 2015. View Article : Google Scholar
|
|
19
|
Li L, Wang M, Mei Z, Cao W, Yang Y, Wang Y
and Wen A: lncRNAs HIF1A-AS2 facilitates the up-regulation of
HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in
HUVECs in hypoxia. Biomed Pharmacother. 96:165–172. 2017.
View Article : Google Scholar
|
|
20
|
Li C, Zhang Y, Zhao W, Cui S and Song Y:
miR-153-3p regulates progression of ovarian carcinoma in vitro and
in vivo by targeting MCL1 gene. J Cell Biochem. 120:19147–19158.
2019. View Article : Google Scholar
|
|
21
|
Wang T, Zhai M, Xu S, Ponnusamy M, Huang
Y, Liu CY, Wang M, Shan C, Shan PP, Gao XQ, et al: NFATc3-dependent
expression of miR-153-3p promotes mitochondrial fragmentation in
cardiac hypertrophy by impairing mitofusin-1 expression.
Theranostics. 10:553–566. 2020. View Article : Google Scholar
|
|
22
|
Canzio D and Maniatis T: The generation of
a protocadherin cell-surface recognition code for neural circuit
assembly. Curr Opin Neurobiol. 59:213–220. 2019. View Article : Google Scholar
|
|
23
|
Goodman KM, Rubinstein R, Dan H, Bahna F,
Mannepalli S, Ahlsén G, Aye Thu C, Sampogna RV, Maniatis T, Honig
B, et al: Protocadherin cis-dimer architecture and recognition unit
diversity. Proc Natl Acad Sci USA. 114:E9829–E9837. 2017.
View Article : Google Scholar
|
|
24
|
Strehl S, Glatt K, Liu QM, Glatt H and
Lalande M: Characterization of two novel protocadherins (PCDH8 and
PCDH9) localized on human chromosome 13 and mouse chromosome 14.
Genomics. 53:81–89. 1998. View Article : Google Scholar
|
|
25
|
Frank M, Ebert M, Shan W, Phillips GR,
Arndt K, Colman DR and Kemler R: Differential expression of
individual gamma-protocadherins during mouse brain development. Mol
Cell Neurosci. 29:603–616. 2005. View Article : Google Scholar
|
|
26
|
Hirayama T and Yagi T: Regulation of
clustered protocadherin genes in individual neurons. Semin Cell Dev
Biol. 69:122–130. 2017. View Article : Google Scholar
|
|
27
|
Weng J, Xiao J, Mi Y, Fang X, Sun Y, Li S,
Qin Z, Li X, Liu T, Zhao S, et al: PCDHGA9 acts as a tumor
suppressor to induce tumor cell apoptosis and autophagy and inhibit
the EMT process in human gastric cancer. Cell Death Dis. 9:272018.
View Article : Google Scholar
|
|
28
|
Weng J, Li S, Lin H, Mei H, Liu Y, Xiao C,
Zhu Z, Cai W, Ding X, Mi Y, et al: PCDHGA9 represses
epithelial-mesenchymal transition and metastatic potential in
gastric cancer cells by reducing β-catenin transcriptional
activity. Cell Death Dis. 11:2062020. View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. µethods. 25:402–408. 2001.
|
|
30
|
Chiang HR, Schoenfeld LW, Ruby JG, Auyeung
VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, et al:
Mammalian microRNAs: Experimental evaluation of novel and
previously annotated genes. Genes Dev. 24:992–1009. 2010.
View Article : Google Scholar
|
|
31
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar
|
|
32
|
Chandrashekar DS, Bashel B, Balasubramanya
SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV and Varambally
S: UALCAN: A portal for facilitating tumor subgroup gene expression
and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar
|
|
33
|
Pontén F, Jirström K and Uhlen M: The
Human Protein Atlas - a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar
|
|
34
|
Jamal-Hanjani M, Wilson GA, McGranahan N,
Birkbak NJ, Watkins TB, Veeriah S, Shafi S, Johnson DH, Mitter R,
Rosenthal R, et al TRACERx Consortium, : Tracking the evolution of
non-small-cell lung cancer. N Engl J Med. 376:2109–2121. 2017.
View Article : Google Scholar
|
|
35
|
Blandin Knight S, Crosbie PA, Balata H,
Chudziak J, Hussell T and Dive C: Progress and prospects of early
detection in lung cancer. Open Biol. 7:1700702017. View Article : Google Scholar
|
|
36
|
Tulchinsky E, Demidov O, Kriajevska M,
Barlev NA and Imyanitov E: EMT: A mechanism for escape from
EGFR-targeted therapy in lung cancer. Biochim Biophys Acta Rev
Cancer. 1871:29–39. 2019. View Article : Google Scholar
|
|
37
|
Otsuki Y, Saya H and Arima Y: Prospects
for new lung cancer treatments that target EMT signaling. Dev Dyn.
247:462–472. 2018. View Article : Google Scholar
|
|
38
|
Zhang X, Sai B, Wang F, Wang L, Wang Y,
Zheng L, Li G, Tang J and Xiang J: Hypoxic BMSC-derived exosomal
miRNAs promote metastasis of lung cancer cells via STAT3-induced
EMT. Mol Cancer. 18:402019. View Article : Google Scholar
|
|
39
|
Zhong W, Yang W, Qin Y, Gu W, Xue Y, Tang
Y, Xu H, Wang H, Zhang C, Wang C, et al: 6-Gingerol stabilized the
p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel
normalization and suppresses tumor progression. J Exp Clin Cancer
Res. 38:2852019. View Article : Google Scholar
|
|
40
|
Xiao T, Zhong W, Zhao J, Qian B, Liu H,
Chen S, Qiao K, Lei Y, Zong S, Wang H, et al: Polyphyllin I
suppresses the formation of vasculogenic mimicry via
Twist1/VE-cadherin pathway. Cell Death Dis. 9:9062018. View Article : Google Scholar
|
|
41
|
Zhang Q, Li X, Li X, Li X and Chen Z:
LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by
targeting miR-484 in human lung cancer cells. J Cell Biochem.
119:4447–4457. 2018. View Article : Google Scholar
|
|
42
|
Gong W, Su Y, Liu Y, Sun P and Wang X:
Long non-coding RNA Linc00662 promotes cell invasion and
contributes to cancer stem cell-like phenotypes in lung cancer
cells. J Biochem. 164:461–469. 2018. View Article : Google Scholar
|
|
43
|
Bartl J, Forget A, Zanini M, Picard D, Qin
N, Borkhardt A, Reifenberger G, Ayrault O and Remke M: SIG-03.
HHIP-AS1 promotes tumor survival through stabilizing dynein Complex
1 in hedgehog driven human brain tumors. Neuro Oncol. 21 (Suppl
2):ii113–ii114. 2019. View Article : Google Scholar
|
|
44
|
Ma R, Wang C, Wang J, Wang D and Xu J:
miRNA-mRNA interaction network in non-small cell lung cancer.
Interdiscip Sci. 8:209–219. 2016. View Article : Google Scholar
|
|
45
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
46
|
Bartl J, Picard D, Borkhardt A,
Reifenberger G and Remke M: Targeting the long non-coding RNA
HHIP-AS1 in sonic hedgehog driven brain tumors. Klin Padiatr.
228:A52016. View Article : Google Scholar
|
|
47
|
Wang H, Zhong W, Zhao J, Zhang H, Zhang Q,
Liang Y, Chen S, Liu H, Zong S, Tian Y, et al: Oleanolic acid
inhibits epithelial-mesenchymal transition of hepatocellular
carcinoma by promoting iNOS dimerization. Mol Cancer Ther.
18:62–74. 2019. View Article : Google Scholar
|
|
48
|
Chiou G-Y, Cherng J-Y, Hsu H-S, Wang ML,
Tsai CM, Lu KH, Chien Y, Hung SC, Chen YW, Wong CI, et al: Cationic
polyurethanes-short branch PEI-mediated delivery of Mir145
inhibited epithelial-mesenchymal transdifferentiation and cancer
stem-like properties and in lung adenocarcinoma. J Control Release.
159:240–250. 2012. View Article : Google Scholar
|
